What Is Gastroesophageal Reflux Disease?
Gastroesophageal reflux disease (GERD) occurs when acidic stomach contents repeatedly return to the esophagus, causing bothersome symptoms and/or complications. It is important to distinguish this from physiologic regurgitation — occasional reflux episodes are normal and do not constitute disease.
GERD affects between 10% and 30% of the population in Western countries, with rising prevalence globally. It\'s one of the most common gastrointestinal conditions and a leading reason for prescribing proton pump inhibitors.
Clinical presentation varies widely: from mild occasional heartburn to severe erosive esophagitis, esophageal stricture, or Barrett\'s esophagus. Symptom severity doesn\'t always correlate with the extent of mucosal lesions.
Antireflux Barrier
GERD results from failure of the antireflux barrier at the esophagogastric junction, especially the lower esophageal sphincter and the crural diaphragm.
Mucosal Injury
Acid and pepsin from gastric juice attack the esophageal mucosa, which lacks the same protection as the gastric mucosa.
High Prevalence
Affects 10-30% of the Western population. It's the most common cause of heartburn and acid regurgitation.
Pathophysiology
GERD results from an imbalance between esophageal defense mechanisms and aggressive factors. The antireflux barrier is composed of the lower esophageal sphincter (LES), the crural diaphragm, and the angle of His. Failure of these mechanisms allows pathologic reflux.
Transient LES relaxations (TLESRs) — relaxations not related to swallowing — are the main mechanism in most patients. These relaxations are mediated by vagal reflexes and may be exacerbated by gastric distension, supine position, and certain foods.
Hiatal Hernia and Acid Pocket
Hiatal hernia displaces the LES into the thorax, reducing antireflux barrier pressure and impairing esophageal clearance. It is present in 50-90% of patients with erosive esophagitis and is an important risk factor for severe GERD.
The postprandial acid pocket is a layer of unbuffered acid that forms above the food contents in the gastric fundus after meals. This pocket is the main source of postprandial reflux, especially in patients with hiatal hernia.
Symptoms
GERD symptoms are divided into typical (esophageal) and atypical (extraesophageal). Typical symptoms — heartburn and regurgitation — are the most common and specific for diagnosis.
Symptoms of GERD
- 01
Heartburn (pyrosis)
Ascending retrosternal burning, typically after meals and on lying down. The most characteristic symptom of GERD.
- 02
Acid regurgitation
Return of acidic gastric contents to the pharynx or mouth without vomiting effort. Leaves an acid or bitter taste.
- 03
Noncardiac chest pain
Retrosternal pain that may simulate angina. GERD is the most common esophageal cause of noncardiac chest pain.
- 04
Chronic cough
Persistent dry cough, especially nocturnal. GERD is one of the three most common causes of chronic cough.
- 05
Posterior laryngitis
Hoarseness, chronic throat clearing, and globus sensation from laryngopharyngeal reflux.
- 06
Dental erosion
Dental enamel wear from acid exposure, especially on the lingual surfaces of the upper teeth.
- 07
Dysphagia
Difficulty swallowing, which may indicate peptic stricture or severe esophagitis. Requires endoscopic investigation.
Diagnosis
GERD diagnosis can be clinical, based on response to empiric PPI treatment, or instrumental. Upper endoscopy evaluates the esophageal mucosa, while 24-hour pH monitoring objectively quantifies esophageal acid exposure.
Endoscopy is indicated when there are alarm signs, PPI-refractory symptoms, or suspected complications. Most patients with GERD (60-70%) have a normal endoscopy — so-called nonerosive reflux disease (NERD).
LOS ANGELES ENDOSCOPIC CLASSIFICATION
| GRADE | DESCRIPTION | SEVERITY |
|---|---|---|
| A | Erosions less than 5mm, nonconfluent | Mild |
| B | Erosions greater than 5mm, nonconfluent | Moderate |
| C | Confluent erosions covering less than 75% of the circumference | Severe |
| D | Confluent erosions covering 75% or more of the circumference | Very severe |
DIAGNÓSTICO DIFERENCIAL
Differential Diagnosis
Functional Dyspepsia
Read more →- Epigastric pain without retrosternal heartburn
- No clear correlation with position
- Normal endoscopy
Testes Diagnósticos
- Endoscopy
- pH monitoring
Eosinophilic Esophagitis
- Episodic dysphagia for solids
- Food impaction
- Young patients with atopy
Testes Diagnósticos
- Endoscopy with biopsy
- Eosinophil count
Achalasia
- Progressive dysphagia for solids and liquids
- Regurgitation of undigested food
- No heartburn
Testes Diagnósticos
- Esophageal manometry
- Esophagogram
Cardiac Chest Pain
- Pressing pain radiating to the arm
- Cardiovascular risk factors
- Worsens with exertion
- Chest pain with risk factors = rule out cardiac
Testes Diagnósticos
- ECG
- Troponin
Drug-Induced Esophagitis
- Use of NSAIDs, bisphosphonates, doxycycline
- Retrosternal pain on swallowing
- Onset associated with the medication
Testes Diagnósticos
- Endoscopy
- Pharmacologic history
Cardiac Chest Pain: Priority for Exclusion
Chest pain is a high-risk symptom that requires ruling out a cardiac cause before any gastroenterologic approach. Angina and acute myocardial infarction may present with pressing, burning, or pressure pain in the chest, easily confused with heartburn. Cardiovascular risk factors (hypertension, diabetes, smoking, dyslipidemia, family history), worsening with physical exertion, and radiation to the left arm or jaw are signs that mandate urgent cardiac evaluation with ECG and troponin.
Even in patients with known GERD, atypical chest pain episodes or those more intense than usual should be investigated from a cardiac standpoint. Physicians should have a low threshold to order an ECG in any patient with chest pain, especially over age 40. The esophageal workup is pursued only after a cardiac cause has been ruled out.
Achalasia and Eosinophilic Esophagitis: Dysphagia as a Warning Sign
Achalasia is an esophageal motor disorder characterized by progressive dysphagia for both solids and liquids — unlike GERD, which doesn\'t cause significant dysphagia. Regurgitation of undigested (nonacidic) food and the absence of heartburn clinically distinguish achalasia. High-resolution esophageal manometry is the confirmatory test, showing absent LES relaxation and aperistalsis of the esophageal body.
Eosinophilic esophagitis predominantly affects children, adolescents, and young adults with a history of atopy. It\'s characterized by episodic dysphagia for solids and food impaction episodes — food gets "stuck" in the esophagus. Endoscopy shows characteristic features (esophageal rings, longitudinal furrows, whitish plaques), and biopsy confirms the diagnosis by an eosinophil count >15 per high-power field. It doesn\'t respond to PPIs — it requires topical corticosteroid and an elimination diet.
Drug-Induced Esophagitis and Functional Dyspepsia
Drug-induced esophagitis is caused by prolonged pill contact with the esophageal mucosa — frequently from taking pills with little water or while lying down. Doxycycline, bisphosphonates, NSAIDs, and potassium chloride are the most common agents. It presents as retrosternal pain on swallowing (odynophagia), with onset clearly linked to the medication. Detailed pharmacologic history and endoscopy clarify the diagnosis.
Functional dyspepsia and GERD coexist in up to 40% of patients and differ in the predominant symptom location: retrosternal heartburn and acid regurgitation in GERD versus epigastric pain, fullness, and bloating in functional dyspepsia. Esophageal pH monitoring documents pathologic acid reflux and is the reference test when endoscopy is normal and symptoms persist. Physicians may opt for an empiric PPI trial as an initial diagnostic strategy in cases without red flags.
Treatment
GERD treatment combines lifestyle modifications, pharmacotherapy, and, in selected cases, antireflux surgery. PPIs are the most effective pharmacologic treatment, with esophagitis healing rates above 80%.
Behavioral measures with the best evidence include weight loss (in overweight patients), head-of-bed elevation, avoiding meals 2-3 hours before lying down, and smoking cessation. Specific dietary restrictions have limited evidence.
Laparoscopic Nissen fundoplication is the standard surgical procedure for refractory or complicated GERD. New endoscopic procedures such as TIF (transoral incisionless fundoplication) offer less-invasive alternatives in selected cases.
Behavioral Measures
Head-of-bed elevation, weight loss, avoiding late meals, smoking cessation. Effective as adjuncts and may be sufficient in mild cases.
PPI Pharmacotherapy
PPIs at standard dose for 4-8 weeks. 80-90% efficacy in esophagitis healing. Double the dose if response is insufficient.
Maintenance Therapy
PPI at the lowest effective dose for patients with relapse after discontinuation. On-demand use is an option for NERD.
Antireflux Surgery
Laparoscopic fundoplication for documented GERD with good response to PPI but desire to discontinue medication, or GERD with refractory regurgitation.
Acupuncture as Treatment
Acupuncture has been studied as a complementary therapy for GERD. Proposed mechanisms — suggested mainly by experimental studies and small trials (e.g., Dickman et al. 2007) — include possible modulation of lower esophageal sphincter pressure, transient LES relaxations, and gastric motility. The clinical translation of these mechanisms into robust outcomes is still limited.
Experimental studies suggest that electroacupuncture may increase basal LES pressure and reduce the number of acid reflux episodes in case series; the clinical data are preliminary. Clinical trials suggest that acupuncture as an adjunct to PPI may improve symptoms in patients with partial response to pharmacotherapy.
Acupuncture may be particularly useful in patients with functional GERD (heartburn without pathologic acid exposure), where the esophageal hypersensitivity component is predominant. A typical protocol involves 8-12 sessions, with periodic assessments of symptomatic response.
Prognosis
GERD is a chronic condition in most patients. Meta-analyses show relapse in 60-80% of patients with erosive esophagitis within 6-12 months after PPI discontinuation, with greater recurrence in more severe esophagitis. Nonerosive GERD has a better prognosis, allowing intermittent or on-demand medication use.
The main long-term complication is Barrett\'s esophagus — intestinal metaplasia of the esophageal mucosa that occurs in 5-15% of patients with chronic esophagitis (proportion varies by population, endoscopic definition, and GERD duration). Barrett is the main risk factor for esophageal adenocarcinoma; progression is rare (0.12-0.33% per year in nondysplastic Barrett; higher in low-/high-grade dysplasia) according to ACG 2016 and BOB CAT.
Peptic stricture, esophageal ulcers, and hemorrhage are rare complications with adequate PPI use. Long-term management aims to control symptoms, heal the mucosa, and prevent complications at the lowest possible therapeutic cost.
Myths and Facts
Myth vs. Fact
Reflux is caused by excess acid in the stomach
In most cases, acid production is normal. The problem is antireflux barrier failure — acid goes where it shouldn't, not that there's too much acid.
Drinking milk relieves heartburn
Milk may briefly relieve heartburn, but its calcium and proteins stimulate gastric acid production, potentially worsening reflux later. It's not recommended as a treatment.
Omeprazole can be taken indefinitely without concern
Although PPIs are safe for most patients, chronic use requires periodic reassessment. Current guidelines recommend the lowest effective dose for the shortest necessary time.
Reflux always causes esophageal cancer
Progression to cancer is rare. Less than 15% of patients with GERD develop Barrett's esophagus, and of these, fewer than 0.5% per year progress to adenocarcinoma. Adequate endoscopic surveillance further reduces this risk.
Only those with heartburn have reflux
GERD can manifest with atypical symptoms such as chronic cough, hoarseness, laryngitis, asthma, dental erosion, or chest pain, without significant heartburn.
When to Seek Help
Occasional heartburn is common and can be managed with antacids. However, frequent or progressive symptoms require medical evaluation for proper diagnosis and prevention of complications.
Frequently Asked Questions about Gastroesophageal Reflux Disease (GERD)
Gastroesophageal Reflux Disease (GERD) is a chronic condition in which gastric contents return to the esophagus frequently enough to cause bothersome symptoms or complications — heartburn and regurgitation at least 2 times per week for more than 3 months. Occasional heartburn, especially after large meals or specific foods, is common in the general population and does not constitute GERD. Frequency, intensity, and impact on quality of life distinguish the physiologic from the pathologic condition.
Yes, in untreated or poorly controlled cases. Main complications include: erosive esophagitis (inflammation with mucosal erosions), esophageal stricture (narrowing from scarring), Barrett's esophagus (intestinal metaplasia of the esophageal mucosa, present in 5-15% of patients with chronic GERD) and, rarely, esophageal adenocarcinoma (0.5% per year risk in Barrett). For this reason, adequate treatment and endoscopic follow-up in Barrett cases are essential.
Main triggers are: fats (which relax the lower esophageal sphincter), chocolate, mint, coffee, alcohol, citrus, tomato, and carbonated drinks. Large meals, lying down soon after eating, and eating late at night also worsen symptoms. Measures with robust evidence include elevating the head of the bed 15-20 cm, waiting 2-3 hours after the last meal before lying down, and reducing body weight (in obese patients). Diet should be individualized to each patient's triggers.
PPIs are effective and generally safe for most patients. Prolonged use (years) has been associated with potential risks: magnesium and vitamin B12 deficiency, osteoporosis, C. difficile intestinal infections, and pneumonia. These risks are modest for most patients. Physicians should periodically reassess the need for maintenance — many patients can reduce the dose or use PPIs on demand after initial control. Never discontinue PPIs abruptly without medical guidance.
Barrett's esophagus is a change in the esophageal mucosa where normal squamous epithelium is replaced by columnar epithelium with intestinal metaplasia, in response to chronic acid injury. It's identified by endoscopy with biopsy and occurs in 5-15% of patients with long-standing GERD. Barrett matters because it increases esophageal adenocarcinoma risk. Patients with Barrett require periodic endoscopic surveillance (every 3-5 years, depending on the degree of dysplasia) and continuous PPI treatment per ACG/AGA guidelines (with serial endoscopic follow-up; the benefit of PPIs as adenocarcinoma chemoprevention is still debated, with modest support in the AspECT trial).
Clinical and experimental studies suggest that acupuncture may reduce the frequency of transient lower esophageal sphincter relaxations, modulate gastric motility, and influence esophageal visceral hypersensitivity. The evidence is preliminary and heterogeneous. Acupuncture is indicated only as a complementary treatment to PPIs and lifestyle measures — it doesn't replace pharmacologic therapy, and the decision to maintain or adjust medication is always made by the attending physician. Conducted by a physician acupuncturist, generally in cycles of 10-12 sessions.
Fundoplication (Nissen surgery) is indicated in selected cases: documented GERD refractory to optimized PPI doses, complications such as recurrent severe esophagitis, large hiatal hernia, persistent extraesophageal symptoms, or patient preference not to use medication long term. Antireflux surgery (Nissen fundoplication) shows satisfaction of 60-80% at 5-10 years in experienced centers; long-term data (LOTUS/REFLUX) show that 20-30% of patients return to PPI use, but it is not free of risks — postoperative dysphagia occurs in 5-10% of cases.
Yes. Extraesophageal manifestations of GERD include chronic cough (GERD is one of the leading causes of unexplained cough), morning hoarseness, posterior laryngitis, globus pharyngeus sensation, difficult-to-control asthma, and even dental erosion from acid. These symptoms occur from high reflux reaching the larynx and airway. They're frequently misattributed to other causes. pH monitoring with a pharyngeal sensor can confirm laryngopharyngeal reflux.
Yes. Classic GERD is caused by acidic reflux. However, some patients have nonacidic reflux (bile, alkaline contents) or weakly acidic reflux — the reflux pH is in the normal range but still causes symptoms from esophageal hypersensitivity. These cases don't respond well to PPIs. Multichannel impedance pH monitoring is the test that distinguishes reflux types and guides individualized treatment.
Seek immediate evaluation if you have: difficulty swallowing (dysphagia) or pain on swallowing (odynophagia); vomiting blood or dark stools; involuntary weight loss; severe chest pain (rule out infarction before treating the esophagus); or a sensation of food stuck in the esophagus. Even without urgency, consult a physician if heartburn occurs more than twice a week, doesn't improve with PPI, or if you've had symptoms for more than 5 years without prior endoscopy.
Related Reading
Deepen your knowledge with related articles